Science Explorer Interactive view Map
Hospital / health system · Yokkaichi · Japan

Yokkaichi Social Insurance Hospital

yokkaichi.jcho.go.jpROR OpenAlex
World rank, all time
#37,071
of 42,892
Rank in Japan
#1,658
of 2,112
Research works
158
▼ 35% vs 2013–17
Citations
3.6k
22.8 per fractional work
Top-10% rate
22.4%
record average 16.5%
Open access
54%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.61× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.98× its world share, 0 worksImmunology and Micro…Neuroscience: 0.04× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.63× its world share, 0 worksPharmacology, Toxico…Engineering: 0.14× its world share, 0 worksEngineeringMedicine: 3.95× its world share, 8 worksMedicineNursing: 6.32× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 6.3×. Every wedge is a field page.

Who are the top researchers at Yokkaichi Social Insurance Hospital?

Ranked on the composite score, Takayuki Yamamoto lead among researchers whose main affiliation is Yokkaichi Social Insurance Hospital.

  1. 1 Takayuki Yamamoto Japan · #85,075 worldwide 216 citations · 51 works
All ranked researchers at Yokkaichi Social Insurance Hospital

Which keywords describe research at Yokkaichi Social Insurance Hospital?

By fractional works in all years, weighted toward what it does more of than the world: Inflammatory Bowel Disease, Epidemiology, Pathogenesis, Crohn's Disease, Genetics, Immunology, Ulcerative Colitis and Proton Pump Inhibitors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammatory Bowel Disease42▲ 252×4 topics
  2. Epidemiology41▲ 6.5×33 topics
  3. Pathogenesis28▲ 32×4 topics
  4. Crohn's Disease26▲ 209×2 topics
  5. Genetics25▲ 21×3 topics
  6. Immunology25▲ 134×1 topic
  7. Ulcerative Colitis25▲ 453×1 topic
  8. Inflammation13▲ 3.5×32 topics
  9. Proton Pump Inhibitors12▲ 88×2 topics
  10. Treatment11▲ 5.6×17 topics
  11. Collagenous Colitis11▲ 275×1 topic
  12. Microscopic Colitis11▲ 275×1 topic
  13. Diagnosis9▲ 5.4×18 topics
  14. Chemotherapy8▲ 7.3×12 topics
  15. Management7▲ 5.6×11 topics
  16. Pyoderma Gangrenosum5▲ 208×1 topic
  17. Sweet's Syndrome5▲ 208×1 topic
  18. Probiotics5▲ 12×2 topics
  19. Prognostic Factors5▲ 6.6×9 topics
  20. Guidelines4▲ 6.0×10 topics
  21. Immunotherapy4▲ 4.4×7 topics
  22. Metastasis4▲ 7.3×6 topics
  23. Antibiotic Resistance4▲ 5.8×6 topics
  24. Children3▲ 8.3×4 topics
  25. Autoantibodies3▲ 8.8×5 topics
  26. Gastric Cancer3▲ 16×3 topics
  27. Immunosuppressive Therapy3▲ 11×6 topics
  28. Colonic Diverticulitis3▲ 85×1 topic
  29. Diverticulitis3▲ 85×1 topic
  30. Preterm Infants3▲ 12×2 topics
  31. Inflammatory Diseases3▲ 16×3 topics
  32. Nutritional Significance3▲ 13×2 topics
  33. Adverse Drug Reactions3▲ 27×2 topics
  34. Critical Care3▲ 7.9×3 topics
  35. Human Milk Composition3▲ 60×1 topic
  36. Necrotizing Enterocolitis3▲ 60×1 topic
  37. Tumor Markers3▲ 25×2 topics
  38. Clinical Pharmacy3▲ 106×1 topic
  39. Intestinal Permeability3▲ 34×2 topics
  40. Pharmaceutical Care3▲ 106×1 topic

Which research topics does Yokkaichi Social Insurance Hospital publish most on?

By volume in 2022–2025: Inflammatory Bowel Disease, Neuroendocrine Tumor Research Advances, Microscopic Colitis and Neuroblastoma Research and Treatments.

Inflammatory Bowel Disease1Inflammatory Bowel Disease: 1 fractional worksNeuroendocrine Tumor Research Advances: 1 fractional worksMicroscopic Colitis: 1 fractional worksNeuroblastoma Research and Treatments: 0 fractional worksPancreatic and Hepatic Oncology Research: 0 fractional worksAnorectal Disease Treatm…0Anorectal Disease Treatments and Outcomes: 0 fractional worksCeliac Disease Research and Management: 0 fractional worksOmental and Epiploic Conditions: 0 fractional worksClusterin in disease pathology: 0 fractional worksBiliary and Gastrointestinal Fistulas: 0 fractional works
GeneticsEpidemiologyNeurologyOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Inflammatory Bowel Disease Genetics 1 works
  2. 2 Neuroendocrine Tumor Research Advances Epidemiology 1 works
  3. 3 Microscopic Colitis Epidemiology 1 works
  4. 4 Neuroblastoma Research and Treatments Neurology 0 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
  6. 6 Anorectal Disease Treatments and Outcomes Surgery 0 works
  7. 7 Celiac Disease Research and Management Gastroenterology 0 works
  8. 8 Omental and Epiploic Conditions Rheumatology 0 works
  9. 9 Clusterin in disease pathology Oncology 0 works
  10. 10 Biliary and Gastrointestinal Fistulas Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.0%not open46.0%

World: 28% of research is openly available.

with international co-authors8.7%domestic only91.3%

World: 19% is written across borders.

How has Yokkaichi Social Insurance Hospital's research output changed?

Output in 2018–2022 was 35% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Yokkaichi

All research institutions in Yokkaichi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.